NRD
Nebula Research & Development’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
25,148
+7,469
| +42% | +$363K | 0.1% | 332 |
|
|
2025
Q1 | $602K | Buy |
+17,679
| New | +$602K | 0.06% | 551 |
|
|
2024
Q1 | – | Sell |
-25,065
| Closed | -$1.57M | – | 781 |
|
|
2023
Q4 | $1.57M | Buy |
+25,065
| New | +$1.57M | 0.47% | 15 |
|
|
2023
Q3 | – | Sell |
-5,013
| Closed | -$281K | – | 526 |
|
|
2023
Q2 | $281K | Buy |
+5,013
| New | +$281K | 0.21% | 221 |
|